Our Promise is our north star for ourselves, patients, and society. It builds upon our history of forging life-altering scientific breakthroughs and reminds us that we are on a bolder quest than ever before - to be courageous changemakers in solving the world’s most complex health challenges and improving the lives of all patients. http://spr.ly/6049V62k7
About us
About Genentech We're passionate about finding solutions for people facing the world's most difficult-to-treat conditions. That is why we use cutting-edge science to create and deliver innovative medicines around the globe. To us, science is personal. Making a difference in the lives of millions starts when you make a change in yours. If you’d like to join our team, view our openings at gene.com/careers. Our patient resource center is dedicated to getting patients and caregivers to the right resources. You can reach them at 1 (877) GENENTECH (436-3683) Monday-Friday, 6am-5pm PST or [email protected]. Community Guidelines: 1. We want to foster positive conversation and diverse community around the issues we are passionate about. To that end, we remove profanity, content that contains credible threats or hate speech, content that is aimed at private individuals, personal information meant to harass someone, and repeated unwanted messages. 2. Don’t mention any medicines by name — ours or anyone else’s. Because of the fair balance rules governing our industry, we cannot post any comments that reference any pharmaceutical brand, product, or service. Please do not mention any specific medicines by name, or include any links to third party sites in your comments. 3. This isn’t the place to report or discuss side effects. This site is not intended as a forum for reporting side effects experienced while taking a Genentech product. Instead, you should report any side effects to Genentech Drug Safety at 1-888-835-2555. You can also report side effects of any prescription product directly to the FDA at 1-800-FDA-1088 or by visiting www.FDA.gov/medwatch. 4. Don’t pitch your product or service. Please don't use our page as a place to promote your product or pitch your services. Please also avoid posting links to external sites. We reserve the right to remove any posts that are deemed promotional.
- Website
-
http://www.gene.com
External link for Genentech
- Industry
- Biotechnology Research
- Company size
- 10,001+ employees
- Headquarters
- South San Francisco, California
- Type
- Privately Held
- Founded
- 1976
- Specialties
- Oncology, Immunology, Disorders of Tissue Growth and Repair, Neuroscience and Infectious Disease, Metabolism, and Ophthalmology
Locations
-
Primary
1 Dna Way
South San Francisco, California 94080, US
-
1000 New Horizons Way
Vacaville, California 95688, US
-
1 Antibody Way
Oceanside, California 92056, US
-
4625 NE Brookwood Pkwy
Hillsboro, Oregon 97124, US
Employees at Genentech
Updates
-
We’re working to better understand how to best manage #MultipleSclerosis (MS) care through pregnancy and nursing. Watch more to find out how we’re coming together to tackle these health challenges for our community of patients. http://spr.ly/6041WUXtv #ECTRIMS2024
Life Planning with MS
-
We were named among Fast Company's Best Workplaces for Innovators, an annual roundup of companies celebrated for cultures that empower employees at all levels to bring groundbreaking ideas to life. This recognition is a testament to the ingenuity of our employees whose passion, dedication, and pursuit of excellence never ceases to amaze us. We’re grateful for everything they do to challenge the status quo and drive our mission forward! http://spr.ly/6043Wc8xF #FCBestWorkplaces
-
-
We're delighted to collaborate with organizations like Jobs for the Future (JFF) and Discovery Education to cultivate a diverse STEM workforce. Join the upcoming LinkedIn Live to learn more:
Expanding Talent Pipelines through K-12 Career Exploration
www.linkedin.com
-
Artificial intelligence is becoming a key focal point in discussions around drug discovery and development. But how is it actually applied? In S5E06 of our podcast, cancer researcher Louis Vermeulen lays out how his team is leveraging AI to study different molecular subgroups of cancer. Learn how this could speed up their timeline for finding much-needed therapeutic solutions: http://spr.ly/6045mkj1S
-
In our latest episode of Two Scientists Walk Into a Bar, cancer researcher Louis Vermeulen discusses the latest advancements in oncology, including new technologies and methods we can leverage to diagnose and treat cancer. Listen to a snippet of his conversation with host Maria Wilson below. http://spr.ly/6043mjbZD
Cancer Conversations: Early Detection and Potent Solutions
-
Recently at our South San Francisco campus, we were honored to host a bipartisan group of congressional staff in connection with Center Forward's Health Innovation Conference. We were inspired by the dialogue and our collective passion for discovering, developing and delivering transformative medicines to patients. Thank you to Center Forward and to all of the attendees for dedicating time for these discussions.
Center Forward recently hosted our first-ever Healthcare Innovation Conference in San Francisco, California. As an organization dedicated to fostering solutions-focused dialogue, this was an opportunity to convene a bipartisan cohort of congressional staff to tour some of the leading innovators contributing to healthcare breakthroughs in the Bay Area and explore cutting-edge advancements. It was an honor to connect with leaders in healthcare and congressional staff who are passionate about advancing healthcare, improving patient outcomes, and cutting through the gridlock to solve the challenges facing the American people.
-
-
Groundbreaking treatments like checkpoint inhibitors have transformed the oncology field. And our VP of Discovery Oncology, Louis Vermeulen, anticipates even more innovative treatments on the horizon. In our latest Two Scientists Walk Into a Bar episode, he shares how scientists are pushing the boundaries of oncology research to drive forward new therapies. Listen to the full episode: https://lnkd.in/gUpnhqMD
-
We recently conducted a survey to research the gaps in knowledge and care for #MultipleSclerosis (MS). We then hosted a live panel, moderated by Robin Arzon, Vice President of Fitness Programming and Head Instructor at Peloton, along with several women from the MS community, including Mitzi Joi Williams M.D., FAAN, Victoria Marie Reese, and Julie Stamm. The panel took a deeper dive into the role healthcare providers play in the diagnosis and treatment journey of people living with MS and opened a discussion on how we can improve care.
-
Breast cancer is one of the most common cancers in women in the U.S. and certain mutations, such as PIK3CA, can lead to worse outcomes. Early comprehensive biomarker testing can detect common mutations like PIK3CA and provide actionable information to inform a more personalized and precise treatment approach. Learn more about PIK3CA in the video below.